Bristol-Myers Squibb Buys VC-backed Amira Pharma

Bristol-Myers Squibb Co. will acquire privately held Amira Pharmaceuticals in an all-cash transaction worth up to $475 million. The deal includes $325 million upfront, with potential additional milestone payments totaling $150 million, the companies announced Thursday. Amira Pharmaceuticals was backed by investors including Novo A/S, Avalon Ventures, Prospect Venture Partners and Versant Ventures.

North AmericaUSBriefs